Gulfo Adele M. — SEC insider filings
SEC reporting owner CIK 1647102. 43 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 43 filings on record, filed 2020-09-17 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Enpro Inc. (NPO) | Director | 35 | — | — | 41 |
| Myovant Sciences Ltd. (MYOV) | Director | 4 | — | — | 7 |
| NewAmsterdam Pharma Co N.V. (NAMS) | Director | 2 | — | — | 4 |
| Tyra Biosciences, Inc. (TYRA) | Director | 2 | — | — | 2 |
Insider filings — Gulfo Adele M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Enpro Inc. (NPO) | Grant/award (A): 5 (derivative) @ $287.16 · Grant/award (A): 0.57 (derivative) @ $287.16 | EDGAR |
| 2026-06-18 | 4 | Enpro Inc. (NPO) | Grant/award (A): 4 (derivative) @ $363.62 · Grant/award (A): 0.45 (derivative) @ $363.62 | EDGAR |
| 2026-06-01 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 13,160 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Enpro Inc. (NPO) | Grant/award (A): 5 (derivative) @ $250.59 · Grant/award (A): 0.66 (derivative) @ $250.59 | EDGAR |
| 2026-02-12 | 4 | Enpro Inc. (NPO) | Grant/award (A): 567 @ $246.91 | EDGAR |
| 2026-01-09 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 3,400 · Grant/award (A): 15,300 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Enpro Inc. (NPO) | Grant/award (A): 116.75 (derivative) @ $214.13 | EDGAR |
| 2025-12-18 | 4 | Enpro Inc. (NPO) | Grant/award (A): 6 (derivative) @ $205.19 · Grant/award (A): 0.60 (derivative) @ $205.19 | EDGAR |
| 2025-10-01 | 4 | Enpro Inc. (NPO) | Grant/award (A): 110.62 (derivative) @ $226 | EDGAR |
| 2025-09-18 | 4 | Enpro Inc. (NPO) | Grant/award (A): 6 (derivative) @ $217.89 · Grant/award (A): 0.41 (derivative) @ $217.89 | EDGAR |
| 2025-07-01 | 4 | Enpro Inc. (NPO) | Grant/award (A): 130.51 (derivative) @ $191.55 | EDGAR |
| 2025-06-20 | 4 | Enpro Inc. (NPO) | Grant/award (A): 7 (derivative) @ $185.86 · Grant/award (A): 0.26 (derivative) @ $185.86 | EDGAR |
| 2025-04-17 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 10,860 · Grant/award (A): 50,700 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Enpro Inc. (NPO) | Grant/award (A): 154.52 (derivative) @ $161.79 | EDGAR |
| 2025-03-20 | 4 | Enpro Inc. (NPO) | Grant/award (A): 7 (derivative) @ $175.76 | EDGAR |
| 2025-02-13 | 4 | Enpro Inc. (NPO) | Grant/award (A): 685 (derivative) @ $182.27 | EDGAR |
| 2025-01-31 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 37,200 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | Enpro Inc. (NPO) | Grant/award (A): 7 (derivative) @ $175.86 | EDGAR |
| 2024-09-19 | 4 | Enpro Inc. (NPO) | Grant/award (A): 8 (derivative) @ $156.77 | EDGAR |
| 2024-06-24 | 4 | Enpro Inc. (NPO) | Grant/award (A): 8 (derivative) @ $146.91 | EDGAR |
| 2024-03-21 | 4 | Enpro Inc. (NPO) | Grant/award (A): 8 (derivative) @ $159.77 | EDGAR |
| 2024-02-15 | 4 | Enpro Inc. (NPO) | Grant/award (A): 803 @ $155.66 | EDGAR |
| 2023-12-14 | 4 | Enpro Inc. (NPO) | Grant/award (A): 8 (derivative) @ $140.49 | EDGAR |
| 2023-09-14 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 9 (derivative) @ $123.90 | EDGAR |
| 2023-06-15 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 9 (derivative) @ $125.72 | EDGAR |
| 2023-03-16 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 12 (derivative) @ $95.94 | EDGAR |
| 2023-03-10 | 4 | Myovant Sciences Ltd. (MYOV) | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 21,603 (derivative) · Disposition to issuer (D): 21,096 (derivative) | EDGAR |
| 2023-02-17 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 942 @ $116.69 | EDGAR |
| 2022-12-15 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 10 (derivative) @ $107.94 | EDGAR |
| 2022-10-28 | 4 | Myovant Sciences Ltd. (MYOV) | Grant/award (A): 9,859 @ $0 | EDGAR |
| 2022-09-15 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 12 (derivative) @ $90.25 | EDGAR |
| 2022-06-16 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 13 (derivative) @ $87.50 | EDGAR |
| 2022-03-17 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 10 (derivative) @ $106.51 | EDGAR |
| 2022-02-16 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 1,041 @ $105.64 | EDGAR |
| 2021-12-16 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 10 (derivative) @ $106.21 | EDGAR |
| 2021-11-09 | 4 | Myovant Sciences Ltd. (MYOV) | Grant/award (A): 21,096 (derivative) @ $0 | EDGAR |
| 2021-09-17 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 13 (derivative) @ $82.96 | EDGAR |
| 2021-06-17 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 11 (derivative) @ $98.35 | EDGAR |
| 2021-03-18 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 11 (derivative) @ $91.41 | EDGAR |
| 2021-02-18 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 1,432 @ $76.82 | EDGAR |
| 2020-12-18 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 14 (derivative) @ $73.91 | EDGAR |
| 2020-09-18 | 4 | ENPRO INDUSTRIES, INC (NPO) | Grant/award (A): 17 (derivative) @ $57.46 | EDGAR |
| 2020-09-17 | 4 | Myovant Sciences Ltd. (MYOV) | Grant/award (A): 21,603 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs